Suven Life Sciences Ltd

Suven Life Sciences is engaged in providing building blocks (bulk actives, drug intermediates and speciality chemicals) for global life science companies.

  • Market Cap: 436.57 Cr.
  • Current Price: 34.25
  • 52 weeks High / Low 67.50 / 15.04
  • Book Value: 72.49
  • Stock P/E: 20.31
  • Dividend Yield: 4.38 %
  • ROCE: 16.95 %
  • ROE: 9.44 %
  • Sales Growth (3Yrs): 9.93 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 1.00
Edit ratios
Pros:
Company is virtually debt free.
Stock is trading at 0.47 times its book value
Stock is providing a good dividend yield of 4.38%.
Company has been maintaining a healthy dividend payout of 17.33%
Cons:
Company has a low return on equity of 12.14% for last 3 years.
Debtor days have increased from 49.78 to 82.62 days.

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
192 90 2 253 199 1 3
146 79 22 178 140 22 30
Operating Profit 45 10 -20 75 59 -21 -28
OPM % 24% 11% -936% 30% 30% -1,517% -999%
Other Income 8 7 7 4 3 2 6
Interest 1 1 0 2 2 0 0
Depreciation 6 6 1 5 6 1 1
Profit before tax 47 11 -14 72 55 -20 -23
Tax % 45% 64% -3% 47% 53% 2% -0%
Net Profit 26 4 -14 38 26 -20 -23
EPS in Rs 2.04 0.30 -1.13 2.98 2.06 -1.56 -1.79
Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
88 112 117 521 499 543 625 663 456
77 96 105 361 398 414 427 503 371
Operating Profit 11 16 13 159 102 129 198 160 86
OPM % 13% 15% 11% 31% 20% 24% 32% 24% 19%
Other Income 1 1 3 9 19 21 23 24 15
Interest 2 3 5 5 6 6 5 4 3
Depreciation 3 4 4 12 18 21 21 22 13
Profit before tax 6 11 6 152 98 123 196 159 84
Tax % 2% -5% -32% 28% 26% 29% 37% 45%
Net Profit 6 11 8 109 72 87 124 87 22
EPS in Rs 3.74 0.68 8.54 5.64 6.85 9.72 6.83 1.69
Dividend Payout % 39% 26% 35% 7% 35% 15% 15% 22%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:9.93%
TTM:6.10%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:7.87%
TTM:-32.79%
Stock Price CAGR
10 Years:33.75%
5 Years:14.90%
3 Years:38.87%
1 Year:83.25%
Return on Equity
10 Years:%
5 Years:%
3 Years:12.14%
Last Year:9.44%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
5 6 12 13 13 13 13 13 13
Reserves 85 96 95 547 583 654 755 818 910
Borrowings 24 41 55 109 83 71 34 38 122
29 30 38 105 74 78 118 170 192
Total Liabilities 143 173 199 773 751 816 919 1,039 1,237
83 96 110 172 305 306 308 293 284
CWIP 3 5 4 107 7 10 25 111 138
Investments 4 5 2 0 0 301 279 230 342
53 68 83 494 439 199 308 404 473
Total Assets 143 173 199 773 751 816 919 1,039 1,237

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
5 16 4 143 68 109 70 36
-9 -20 -16 -110 -39 -311 -1 -28
3 13 6 179 -68 -30 -52 -23
Net Cash Flow -1 8 -7 212 -39 -232 17 -15

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 11% 8% 13% 15% 24% 17%
Debtor Days 62 53 111 28 39 31 36 83
Inventory Turnover 4.90 4.96 6.04 6.17 5.39 4.47

Recent announcements

View all announcements

Annual reports

Credit ratings